Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
48
NNVC Quote, Financials, Valuation and Earnings
Last price:
$1.24
Seasonality move
:
6.37%
Day range:
$1.23 - $1.33
52-week range:
$1.03 - $3.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.97x
Volume:
175.9K
Avg. volume:
258.6K
1-year change:
9.17%
Market cap:
$20.5M
Revenue:
--
EPS (TTM):
-$0.72
Nanoviricides Number of Institutional Trades
Nanoviricides Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$1.3M
(Last 6 Months)
Current Institutional Ownership Percentage
12.75%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$3.3M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Nanoviricides Institutional Ownership
-
What Percentage Of NNVC Is Owned by Institutions?
12.75% of NNVC is owned by institutions.
-
How Many Institutions Own NNVC Shares?
Nanoviricides stock is owned by 51 institutional shareholders at this time.
-
Have Institutions Been Buying NNVC Stock?
Yes, institutions have bought 540.9K shares of NNVC in the last quarter.
-
Have Institutions Been Selling NNVC Stock?
Yes, institutions have sold 1.2M shares of NNVC over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
